ICON has extensive experience in conducting gastrointestinal studies

We work across the entire drug development spectrum. Our experience ranges from the initial studies in Phase I through post-marketing efforts in Phase IV.

ICON Gastrointestinal experience in last five years

  • 121

    Studies conducted

  • 34,363

    Patients involved

  • 7,973

    Sites worldwide

Broad disease experience

ICON's Gastrointestinal team comprises dedicated drug development experts with significant experience conducting clinical trials for experimental therapeutics in the following diseases:

 

Diseases

  
Acid Reflux Chronic Functional Constipation Indigestion
Acute Gastric Pain Crohn’s Disease Idiopathic Gastroparesis
Acute Pancreatitis Diarrhea Inflammatory Bowel Disease
Bowel Prep Diverticulitis Irritable Bowel Syndrome
Celiac Dyspepsia Irritable Bowel Syndrome with Constipation
Chronic Constipation Eosinophilic Esophagitis Irritable Bowel Syndrome with Diarrhea
Colorectal Conditions Esophagitis Short Bowel Syndrome
Constipation Gastroesophageal Reflux Traveler's Diarrhea
Chronic Idiopathic Constipation GERD Ulcerative Colitis
File Thumbnail

Whitepaper: From genomics to the coming of age glycomics

Glycan biomarkers are quickly becoming key elements of gastrointestinal research, setting the stage for a new golden age of epigenetic research and personalised therapeutics.

File Thumbnail

Case study: The perfect protocol

Learn how "right the first time" leads to early trial delivery

File Thumbnail

Case study: Enrolment challenges - Personalised enrolment solutions for IBD studies

Download our case study to learn about our personalised enrolment solutions for IBD studies.

File Thumbnail

Factsheet: Gastroenterology experience and expertise

ICON offers extensive experience and expertise across numerous indications in gastroenterology.